Table 3. Secondary infections in 191 patients with COVID-19 in an ICU in Brazil, stratified by etiologic agents and sites of infection.
| Acinetobacter baumannii | n = 28 |
|---|---|
| Isolated biological material | |
| Tracheal aspirate | 20 (71.2%) |
| Blood and tracheal aspirate | 3 (10.8) |
| Blood | 2 (7.2%) |
| BAL | 1 (3.6%) |
| Urine | 1 (3.6%) |
| Bone fragment | 1 (3.6%) |
| Type of infection | |
| VAP | 14 (50.0%) |
| Tracheobronchitis | 9 (32.1%) |
| CLABSI | 2 (7.1%) |
| Nosocomial pneumonia | 1 (3.6%) |
| Osteomyelitis | 1 (3.6%) |
| CAUTI | 1 (3.6%) |
| Pseudomonas aeruginosa | n = 22 |
| Isolated biological material | |
| Tracheal aspirate | 17 (77.4%) |
| Blood and tracheal aspirate | 2 (9.1%) |
| Blood | 1 (4.5%) |
| BAL | 1 (4.5%) |
| Bone fragment | 1 (4.5%) |
| Type of infection | |
| VAP | 11 (50.0%) |
| Tracheobronchitis | 8 (36.5%) |
| CLABSI | 1 (4.5%) |
| Nosocomial pneumonia | 1 (4.5%) |
| Osteomyelitis | 1 (4.5%) |
| Klebsiella pneumoniae | n = 14 |
| Isolated biological material | |
| Tracheal aspirate | 6 (42.8%) |
| Blood | 8 (57.2%) |
| Type of infection | |
| VAP | 7 (50.0%) |
| CLABSI | 4 (28.6%) |
| Nosocomial pneumonia | 3 (21.4%) |
| Stenotrophomonas maltophilia | n = 6 |
| Isolated biological material | |
| Tracheal aspirate | 5 (83.3%) |
| Blood and tracheal aspirate | 1 (16.7%) |
| Type of infection | |
| VAP | 5 (83.3%) |
| Tracheobronchitis | 1 (16.7%) |
| Staphylococcus aureus | n = 8 |
| Isolated biological material | |
| Blood | 2 (25.0%) |
| Tracheal aspirate | 4 (50.0%) |
| Blood and tracheal aspirate | 2 (25.0%) |
| Type of infection | |
| VAP | 5 (62.5%) |
| Tracheobronchitis | 1 (12.5%) |
| CLABSI | 1 (12.5%) |
| Endocarditis | 1 (12.5%) |
| Enterococcus faecalis | n = 6 |
| Isolated biological material | |
| Blood | 4 (66.6%) |
| Tracheal aspirate | 1 (16.7%) |
| Urine | 1 (16.7%) |
| Type of infection | |
| CLABSI | 3 (50.0%) |
| CAUTI | 2 (33.3%) |
| VAP | 1 (16.7%) |
| Others | n =13 |
BAL = bronchoalveolar lavage; CAUTI = catheter-associated urinary tract infection; CLABSI = central line-associated bloodstream infections; VAP = ventilator-associated pneumonia.